1.
Mohsen Karimi, Christer Nilsson, Marios Dimitriou, Monika Jansson, Hans Matsson, Per Unneberg, Sören Lehmann, Juha Kere, Eva Hellström-Lindberg. High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia. haematol [Internet]. 2015Jun.1 [cited 2024Apr.18];100(6):e223-e225. Available from: https://haematologica.org/article/view/7418